All In MedTech

Device Trial Radar · NCT04267575

Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites

Last checked: Nov 19, 2026Latest source record: Aug 9, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownResults posted on the registry

Status

Status unknown

Enrollment

20

Actual

Start

Jul 30, 2019

Primary completion

Apr 14, 2021

Study completion Apr 14, 2023

Sponsor

Lead sponsor
Jerome Canady, M.D.Academic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 13, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study designed is to evaluate the safety of Canady Helios™ Cold Plasma Scalpel (CHCPS) in patients with solid tumors with carcinomatosis scheduled to undergo surgical resection for cytoreduction. Patients with stage 4 resectable tumors as decided by a multidisciplinary disease management team may be included if the metastatic disease is non-synchronous (e.g. recurrent colorectal carcinoma with hepatic metastasis amenable for surgical resection).. Plasma is an ionized gas typically generated in high-temperature laboratory conditions. Plasma coagulators are currently used routinely as surgical tools with multiple applications that create temperatures between 37° C to 43°C and cause thermal injury. Earlier studies demonstrated the non-aggressive nature of cold plasma. As evidence accumulates, it is becoming clear that low-temperature cold plasma has an increasing role in biomedical applications.

Conditions

  • Recurrent Malignant Solid Neoplasm
  • Stage IV Breast Cancer
  • Stage IV Prostate Cancer
  • Stage IV Pancreatic Cancer
  • Stage IV Non-small Cell Lung Cancer
  • Stage IV Ovarian Cancer
  • Stage IV Fallopian Tube Cancer
  • Stage IV Colon Cancer
  • Stage IV Colorectal Cancer
  • Stage IV Liver Cancer
  • Stage IV Renal Cell Cancer
  • Stage IV Rectal Cancer
  • Stage IV Lung Cancer
  • Stage IV Small Intestinal Cancer
  • Stage IV Gastric Cancer
  • Stage IV Bladder Cancer

Interventions

  • Canady Helios Cold Plasma ScalpelDevice

    Device used to distribute cold plasma energy at the resected tumor margins.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Complications Due To Cold Plasma ApplicationTime frame: Immediate after application of cold plasma, followed by 3 months, 6 months, 12 months and 15 month observations.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Canady Surgical Group PC

    Washington D.C., District of Columbia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.